Your browser doesn't support javascript.
loading
Disease evolution and outcomes in familial AML with germline CEBPA mutations.
Tawana, Kiran; Wang, Jun; Renneville, Aline; Bödör, Csaba; Hills, Robert; Loveday, Chey; Savic, Aleksandar; Van Delft, Frederik W; Treleaven, Jennifer; Georgiades, Panayiotis; Uglow, Elizabeth; Asou, Norio; Uike, Naokuni; Debeljak, Marusa; Jazbec, Janez; Ancliff, Philip; Gale, Rosemary; Thomas, Xavier; Mialou, Valerie; Döhner, Konstanze; Bullinger, Lars; Mueller, Beatrice; Pabst, Thomas; Stelljes, Matthias; Schlegelberger, Brigitte; Wozniak, Eva; Iqbal, Sameena; Okosun, Jessica; Araf, Shamzah; Frank, Anne-Katrine; Lauridsen, Felicia B; Porse, Bo; Nerlov, Claus; Owen, Carolyn; Dokal, Inderjeet; Gribben, John; Smith, Matthew; Preudhomme, Claude; Chelala, Claude; Cavenagh, Jamie; Fitzgibbon, Jude.
Afiliação
  • Tawana K; Centre for Haemato-Oncology, Barts Cancer Institute, London, United Kingdom;
  • Wang J; Centre for Molecular Oncology, Barts Cancer Institute, London, United Kingdom;
  • Renneville A; Laboratory of Hematology, Biology and Pathology Center, Centre Hospitalier Régional Universitaire of Lille, Lille, France; University of Lille Nord de France, Lille, France; Inserm, UMR387, Team 3, Cancer Research Institute of Lille, Lille, France;
  • Bödör C; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary;
  • Hills R; School of Medicine, Cardiff University, Cardiff, United Kingdom;
  • Loveday C; Centre for Haemato-Oncology, Barts Cancer Institute, London, United Kingdom;
  • Savic A; Clinic of Hematology, Clinical Center of Vojvodina, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia;
  • Van Delft FW; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom; The Institute of Cancer Research, Department of Haemato-Oncology, Sutton, United Kingdom;
  • Treleaven J; The Institute of Cancer Research, Department of Haemato-Oncology, Sutton, United Kingdom;
  • Georgiades P; Centre for Haemato-Oncology, Barts Cancer Institute, London, United Kingdom;
  • Uglow E; Centre for Haemato-Oncology, Barts Cancer Institute, London, United Kingdom;
  • Asou N; Department of Hematology, International Medical Center, Saitama Medical University, Hidaka, Japan;
  • Uike N; Department of Hematology, National Kyushu Cancer Center, Fukuoka, Japan;
  • Debeljak M; Unit for Special laboratory Diagnostics, University Children's Hospital University Medical Center, Ljubljana, Slovenia;
  • Jazbec J; Unit for Hematology and Oncology, University Children's Hospital University Medical Center, Ljubljana, Slovenia;
  • Ancliff P; Department of Haematology, Great Ormond St Hospital, London, United Kingdom;
  • Gale R; Department of Haematology, University College London Cancer Institute, London, United Kingdom;
  • Thomas X; Department of Hematology, Lyon Sud Hospital, Pierre-Bénite, France;
  • Mialou V; Institute of Pediatric Hematology and Oncology, Lyon Hospital, Lyon, France;
  • Döhner K; Department of Internal Medicine III, University of Ulm, Ulm, Germany;
  • Bullinger L; Department of Internal Medicine III, University of Ulm, Ulm, Germany;
  • Mueller B; Hematology/Oncology, Department for Clinical Research and Pediatrics, University Hospital Berne and University Berne, Berne, Switzerland;
  • Pabst T; Hematology/Oncology, Department for Clinical Research and Pediatrics, University Hospital Berne and University Berne, Berne, Switzerland;
  • Stelljes M; Department of Medicine/Hematology and Oncology, University of Muenster, Muenster, Germany;
  • Schlegelberger B; Institute of Human Genetics, Hannover Medical School, Hannover, Germany;
  • Wozniak E; Genome Centre, Barts and the London School of Medicine and Dentristry, London, United Kingdom;
  • Iqbal S; Centre for Haemato-Oncology, Barts Cancer Institute, London, United Kingdom;
  • Okosun J; Centre for Haemato-Oncology, Barts Cancer Institute, London, United Kingdom;
  • Araf S; Centre for Haemato-Oncology, Barts Cancer Institute, London, United Kingdom;
  • Frank AK; The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark;
  • Lauridsen FB; The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark;
  • Porse B; The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark; Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark; Danish Stem Cell Centre (DanStem) Faculty of Health Sciences, University of Copenhagen, Copenhagen,
  • Nerlov C; Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom;
  • Owen C; Division of Hematology and Hematological Malignancies, Foothills Medical Centre, Calgary, Canada; and.
  • Dokal I; Centre for Paediatrics, Blizard Institute, Barts and the London School of Medicine and Dentistry, London, United Kingdom.
  • Gribben J; Centre for Haemato-Oncology, Barts Cancer Institute, London, United Kingdom;
  • Smith M; Centre for Haemato-Oncology, Barts Cancer Institute, London, United Kingdom;
  • Preudhomme C; Laboratory of Hematology, Biology and Pathology Center, Centre Hospitalier Régional Universitaire of Lille, Lille, France; University of Lille Nord de France, Lille, France; Inserm, UMR387, Team 3, Cancer Research Institute of Lille, Lille, France;
  • Chelala C; Centre for Molecular Oncology, Barts Cancer Institute, London, United Kingdom;
  • Cavenagh J; Centre for Haemato-Oncology, Barts Cancer Institute, London, United Kingdom;
  • Fitzgibbon J; Centre for Haemato-Oncology, Barts Cancer Institute, London, United Kingdom;
Blood ; 126(10): 1214-23, 2015 Sep 03.
Article em En | MEDLINE | ID: mdl-26162409
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Mutação em Linhagem Germinativa / Proteínas Estimuladoras de Ligação a CCAAT / Recidiva Local de Neoplasia Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Mutação em Linhagem Germinativa / Proteínas Estimuladoras de Ligação a CCAAT / Recidiva Local de Neoplasia Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article